Loading candles…
Aarti Pharmalabs Ltd was incorporated in 2019 through a demerger from Aarti Industries Limited. The company operates in the pharmaceuticals and nutraceuticals industries, specializing in the manufacturing of active pharmaceutical ingredients (APIs), advanced intermediates, xanthine derivatives, pharmaceuticals, and nutraceuticals. It provides end-to-end solutions from process development to commercial manufacturing. Aarti Pharmalabs maintains a strong global presence with exports to regulated markets including India, the United States, the European Union, and Japan. The company is recognized as a key player in the 'China+1' strategy, utilizing fully backward-integrated manufacturing processes to enhance supply chain resilience.
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 and dividend | 18 May 2026 |
| Unaudited Results - Q3-FY25 | AARTI PHARMALABS LIMITED has informed the Exchange about Board Meeting to be held on 09-Feb-2026 to consider and approve the Quarterly Unaudited Financial re… | 9 Feb 2026 |
| Unaudited Results - FY25 | To consider and approve the unaudited standalone and consolidated financial results for the period ended September 30, 2025 | 9 Nov 2025 |
| Unaudited Results - FY25 | To consider and approve the unaudited financial results for the period ended Jun 30, 2025 | 12 Aug 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025, dividend and other business matters | 10 May 2025 |
Besseggen InfoTech LLP is a SEBI-registered stock broker (Reg. No. INZ000213450), member of NSE (90155 (Cash & F&O)) and BSE (6722 (Cash & F&O)). Investment in securities market are subject to market risks; read all related documents carefully before investing.